Mitrović Z - Search Results

1

High-dose ifosfamide and mitoxantrone (HDIM) in patients with relapsed or refractory Hodgkin's lymphoma.

Aurer I, Nemet D, Mitrović Z, Dujmović D, Bašić-Kinda S, Radman I, Sertić D, Šantek F, Kralik M, Dotlić S, Mazić S, Labar B. Aurer I, et al. Among authors: mitrovic z. Ann Hematol. 2016 Jun;95(7):1129-36. doi: 10.1007/s00277-016-2676-0. Epub 2016 Apr 22. Ann Hematol. 2016. PMID: 27103009

2

[Rituximab in the treatment of indolent non-Hodgkin's lymphoma].

Aurer I, Mitrović Z, Radman I, Kovacević-Metelko J, Nemet D, Serventi-Seiwerth R, Stern-Padovan R, Jakic-Razumović J, Nola M, Zupancić-Salek S, Sertić D, Labar B. Aurer I, et al. Among authors: mitrovic z. Lijec Vjesn. 2004 Nov-Dec;126(11-12):307-11. Lijec Vjesn. 2004. PMID: 16082888 Clinical Trial. Croatian.

3

[Rituximab in the treatment of B-cell non-Hodgkin lymphoma].

Mitrović Z, Aurer I. Mitrović Z, et al. Lijec Vjesn. 2006 Jan-Feb;128(1-2):36-42. Lijec Vjesn. 2006. PMID: 16640226 Review. Croatian.

4

[Treatment of hairy cell leukemia with cladribine].

Aurer I, Mitrović Z, Kovacević-Metelko J, Radman I, Basić-Kinda S, Gjadrov-Kuvezdić K, Jakić-Razumović J, Dubravcić K, Ries S, Nola M, Zupancic-Salek S, Labar B. Aurer I, et al. Among authors: mitrovic z. Lijec Vjesn. 2007 Mar-Apr;129(3-4):80-3. Lijec Vjesn. 2007. PMID: 17557550 Croatian.

5

FCgammaRIIIA and FCgammaRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma.

Mitroviç Z, Aurer I, Radman I, Ajdukoviç R, Sertiç J, Labar B. Mitroviç Z, et al. Haematologica. 2007 Jul;92(7):998-9. doi: 10.3324/haematol.10327. Haematologica. 2007. PMID: 17606457 Free article.

6

[Primary central nervous system lymphoma--a single center experience].

Mitrović Z, Radman I, Aurer I, Petranović D, Santek F, Labar B. Mitrović Z, et al. Lijec Vjesn. 2007 Dec;129(12):391-5. Lijec Vjesn. 2007. PMID: 18383741 Croatian.

7

LightCycler SeptiFast assay as a tool for the rapid diagnosis of sepsis in patients during antimicrobial therapy.

Vince A, Lepej SŽ, Baršić B, Dušek D, Mitrović Z, Serventi-Seiwerth R, Labar B. Vince A, et al. Among authors: mitrovic z. J Med Microbiol. 2008 Oct;57(Pt 10):1306-1307. doi: 10.1099/jmm.0.47797-0. J Med Microbiol. 2008. PMID: 18809565 No abstract available.

8

Treatment of relapsed or refractory aggressive non-hodgkin lymphoma with two ifosfamide-based regimens, IMVP and ICE.

Aurer I, Mitrović Z, Nemet D, Radman I, Sertić D, Serventi-Seiwerth R, Stern-Padovan R, Santek F, Nola M, Mrsić M, Labar B. Aurer I, et al. Among authors: mitrovic z. J Chemother. 2008 Oct;20(5):640-4. doi: 10.1179/joc.2008.20.5.640. J Chemother. 2008. PMID: 19048695 Clinical Trial.

9

CD43 expression is an adverse prognostic factor in diffuse large B-Cell lymphoma.

Mitrovic Z, Ilic I, Nola M, Aurer I, Sonicki Z, Basic-Kinda S, Radman I, Ajdukovic R, Labar B. Mitrovic Z, et al. Clin Lymphoma Myeloma. 2009 Apr;9(2):133-7. doi: 10.3816/CLM.2009.n.033. Clin Lymphoma Myeloma. 2009. PMID: 19406723

10

Lack of prognostic significance of the germinal-center phenotype in diffuse large B-cell lymphoma patients treated with CHOP-like chemotherapy with and without rituximab.

Ilić I, Mitrović Z, Aurer I, Bašić-Kinda S, Radman I, Ajduković R, Labar B, Dotlić S, Nola M. Ilić I, et al. Among authors: mitrovic z. Int J Hematol. 2009 Jul;90(1):74-80. doi: 10.1007/s12185-009-0353-y. Epub 2009 Jun 3. Int J Hematol. 2009. PMID: 19495929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters